The statements in this press release regarding future events, including Caliper's statements concerning strong momentum going in to the fourth quarter of 2011, its belief that the merger with PerkinElmer will be approved by Caliper's stockholders and will close on November 7, 2011, the expectation that the merger with PerkinElmer will further accelerate the adoption and penetration of our innovative offerings and will provide Caliper with greater resources to further develop its unique and innovative pipeline of new technologies and products, and the expectation that the PerkinElmer merger will further catalyze Caliper's profitable growth for many years to come are "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements as a result of a number of factors, including that (i) Caliper's expectations regarding demand for its products and services may not materialize if capital spending by Caliper's customers declines, if customers do not purchase Caliper's products as rapidly as Caliper believes that they will, if competitors introduce new competitive products, or if Caliper is unable to convince potential customers regarding the superior performance of its microfluidic and imaging systems and products, and (ii) Caliper's stockholders may not vote to approve the pending merger with PerkinElmer, Inc.
Further information on risks faced by Caliper are detailed under the caption "Risks Related To Our Business" in Caliper's Annual Report on Form 10-K for the year ended December 31, 2010. Our filings are available on a web site maintained by the Securities and Exchange Commission at http://www.sec.gov. Caliper does not undertake any obli
|SOURCE Caliper Life Sciences, Inc.|
Copyright©2010 PR Newswire.
All rights reserved